On Tuesday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) opened lower -5.19% from the last session, before settling in for the closing price of $2.31. Price fluctuations for IOVA have ranged from $1.64 to $12.51 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 4.17%. Company’s average yearly earnings per share was noted 11.50% at the time writing. With a float of $292.67 million, this company’s outstanding shares have now reached $341.92 million.
Iovance Biotherapeutics Inc (IOVA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Iovance Biotherapeutics Inc is 19.12%, while institutional ownership is 53.83%. The most recent insider transaction that took place on Jun 05 ’25, was worth 55,200. In this transaction Chief Commercial Officer of this company bought 30,000 shares at a rate of $1.84, taking the stock ownership to the 30,000 shares. Before that another transaction happened on May 23 ’25, when Company’s Chief Regulatory Officer bought 5,600 for $1.74, making the entire transaction worth $9,743. This insider now owns 206,852 shares in total.
Iovance Biotherapeutics Inc (IOVA) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.28 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.3) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.84% during the next five years compared to 4.17% growth over the previous five years of trading.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Trading Performance Indicators
Check out the current performance indicators for Iovance Biotherapeutics Inc (IOVA). In the past quarter, the stock posted a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.23, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Iovance Biotherapeutics Inc (IOVA)
The latest stats from [Iovance Biotherapeutics Inc, IOVA] show that its last 5-days average volume of 10.1 million was inferior to 13.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 48.92%.
During the past 100 days, Iovance Biotherapeutics Inc’s (IOVA) raw stochastic average was set at 19.85%, which indicates a significant decrease from 40.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.12 in the past 14 days, which was lower than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.27, while its 200-day Moving Average is $3.08. Now, the first resistance to watch is $2.31. This is followed by the second major resistance level at $2.42. The third major resistance level sits at $2.50. If the price goes on to break the first support level at $2.12, it is likely to go to the next support level at $2.04. The third support level lies at $1.93 if the price breaches the second support level.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Key Stats
There are currently 361,854K shares outstanding in the company with a market cap of 792.46 million. Presently, the company’s annual sales total 164,070 K according to its annual income of -372,180 K. Last quarter, the company’s sales amounted to 59,950 K and its income totaled -111,660 K.
